Fresenius Takes Full Control Of Spanish Biz In €750M Deal
German healthcare company Fresenius said Thursday it has acquired full ownership of a Spanish biopharmaceutical business for up to €750 million ($847 million) in a deal that will allow it to...To view the full article, register now.
Already a subscriber? Click here to view full article